PN
Last reporting period 30 Sep, 2023
Updated —
Last price
—
Market cap $B
1.332
Exchange
XNAS - Nasdaq
158 %
Last period ROIC
What is ROIC ?
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
See also POINT Biopharma
Company Analysis
PNT valuation, rating, competitors, insights and company profile
Eyestock Rating
PNT financial analysis by Eyestock methodology
Valuation
PNT valuation using historical relative method
Statements
PNT Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PNT dividend yield and annual dividend
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
POINT Biopharma`s ROIC for the last twelve months ended 2023-09-30 is 158 %
